TY!
I agree, and I have a firm belief that it will not be a problem.
IMHO the seeming complexities involved are exactly the sort of strategic bread-and-butter work for MT & JC that underpins their commercialisation objectives. They would be right across this stuff.
MT in particular was three steps ahead of us with that unexpected Amylyx meeting; probably remains two steps ahead of the best of us; and easily one step ahead of the rest of us mere mortals.
Unpacking the pipeline strategy, intrigues the investment analyst part of me - and there are plenty here more deeply intimate with biotech strategy -- and for me, the interplay between mechanism of action, and the price-setting aspects, were of special interest, but I await to hear the thoughts of others, to isolate their special viewpoint in this ...
cheers,
Ice
Pipeline-in-a-drug, page-4
-
- There are more pages in this discussion • 58 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $92.46M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 20.0¢ | 19.0¢ | $45.80K | 239.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 103675 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 68506 | 4 |
View Market Depth
| Last trade - 11.34am 04/11/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |